The global demand for Image-guided Therapy Systems Market is presumed to reach the market size of nearly USD 9.02 Billion by 2032 from USD 5.48 Billion in 2023 with a CAGR of 5.68% under the study period 2024-2032.
Image-guided therapy systems are advanced medical technologies integrating imaging techniques with therapeutic procedures to enhance precision and outcomes. These systems combine real-time imaging modalities, such as MRI, CT, or ultrasound, with therapeutic tools to guide and monitor interventions. Image-guided therapy is used in various medical fields, including oncology, cardiology, and neurology, to perform minimally invasive procedures more accurately. The integration of imaging and therapeutic technologies enables clinicians to target specific areas of interest, minimize damage to surrounding tissues, and improve procedural success rates. This approach enhances patient safety, reduces recovery times, and allows for better visualization of complex anatomical structures during treatment.
MARKET DYNAMICS
The image-guided therapy systems market is fuelled by the increasing demand for minimally invasive procedures and the growing prevalence of chronic diseases that necessitate precise interventions. Technological advancements, such as the development of high-resolution imaging and real-time guidance systems, are enhancing the effectiveness of image-guided therapies. The rise of personalized medicine and the focus on improving patient outcomes also contribute to market growth. The expanding applications of image-guided therapy in various medical specialties and the growing adoption of advanced imaging technologies support opportunities in the image-guided therapy systems market. The integration of artificial intelligence & machine learning in image analysis is expected to enhance the capabilities of these systems further. Moreover, the development of healthcare infrastructure in emerging markets offers substantial growth opportunities. However, the high cost of advanced systems and the need for specialized training may hinder image-guided therapy systems' market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Image-guided Therapy Systems. The growth and trends of Image-guided Therapy Systems industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Image-guided Therapy Systems market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
Computed Tomography (CT) Scanners
Ultrasound Systems
Magnetic Resonance Imaging (MRI)
Endoscopes
X-ray Fluoroscopy
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
By Application
Cardiac Surgery
Neurosurgery
Orthopedic Surgery
Urology
Oncology Surgery
Gastroenterology
Others
By End-use
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Research & Academic Institutions
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Image-guided Therapy Systems market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Image-guided Therapy Systems market include Koninklijke Philips N.V., Medtronic, Siemens Healthineers, Analogic Corporation, GE Healthcare, Varian Medical Systems Inc., Brainlab AG, Olympus Corporation, Stryker. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
3. IMAGE-GUIDED THERAPY SYSTEMS - INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By End-use
3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL IMAGE-GUIDED THERAPY SYSTEMS MARKET ANALYSIS BY PRODUCT
5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Computed Tomography (CT) Scanners Historic and Forecast Sales By Regions
5.4. Ultrasound Systems Historic and Forecast Sales By Regions
5.5. Magnetic Resonance Imaging (MRI) Historic and Forecast Sales By Regions
5.6. Endoscopes Historic and Forecast Sales By Regions
5.7. X-ray Fluoroscopy Historic and Forecast Sales By Regions
5.8. Positron Emission Tomography (PET) Historic and Forecast Sales By Regions
5.9. Single Photon Emission Computed Tomography (SPECT) Historic and Forecast Sales By Regions
6. GLOBAL IMAGE-GUIDED THERAPY SYSTEMS MARKET ANALYSIS BY APPLICATION
6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Cardiac Surgery Historic and Forecast Sales By Regions
6.4. Neurosurgery Historic and Forecast Sales By Regions
6.5. Orthopedic Surgery Historic and Forecast Sales By Regions
6.6. Urology Historic and Forecast Sales By Regions
6.7. Oncology Surgery Historic and Forecast Sales By Regions
6.8. Gastroenterology Historic and Forecast Sales By Regions
6.9. Others Historic and Forecast Sales By Regions
7. GLOBAL IMAGE-GUIDED THERAPY SYSTEMS MARKET ANALYSIS BY END-USE
7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
7.5. Specialty Clinics Historic and Forecast Sales By Regions
7.6. Research & Academic Institutions Historic and Forecast Sales By Regions
8. GLOBAL IMAGE-GUIDED THERAPY SYSTEMS MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
8.3.1 Overview, Historic and Forecast Data Sales Analysis
8.3.2 North America By Segment Sales Analysis
8.3.3 North America By Country Sales Analysis
8.3.4 United States Sales Analysis
8.3.5 Canada Sales Analysis
8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
8.4.1 Overview, Historic and Forecast Data Sales Analysis
8.4.2 Europe By Segment Sales Analysis
8.4.3 Europe By Country Sales Analysis
8.4.4 United Kingdom Sales Analysis
8.4.5 France Sales Analysis
8.4.6 Germany Sales Analysis
8.4.7 Italy Sales Analysis
8.4.8 Russia Sales Analysis
8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
8.5.1 Overview, Historic and Forecast Data Sales Analysis
8.5.2 Asia Pacific By Segment Sales Analysis
8.5.3 Asia Pacific By Country Sales Analysis
8.5.4 China Sales Analysis
8.5.5 India Sales Analysis
8.5.6 Japan Sales Analysis
8.5.7 South Korea Sales Analysis
8.5.8 Australia Sales Analysis
8.5.9 South East Asia Sales Analysis
8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
8.6.1 Overview, Historic and Forecast Data Sales Analysis
8.6.2 Latin America By Segment Sales Analysis
8.6.3 Latin America By Country Sales Analysis
8.6.4 Brazil Sales Analysis
8.6.5 Argentina Sales Analysis
8.6.6 Peru Sales Analysis
8.6.7 Chile Sales Analysis
8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
8.7.1 Overview, Historic and Forecast Data Sales Analysis
8.7.2 Middle East & Africa By Segment Sales Analysis
8.7.3 Middle East & Africa By Country Sales Analysis
8.7.4 Saudi Arabia Sales Analysis
8.7.5 UAE Sales Analysis
8.7.6 Israel Sales Analysis
8.7.7 South Africa Sales Analysis
8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE IMAGE-GUIDED THERAPY SYSTEMS COMPANIES
9.1. Image-guided Therapy Systems Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10. COMPANY PROFILES OF IMAGE-GUIDED THERAPY SYSTEMS INDUSTRY
10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Koninklijke Philips N.V.
10.3.1 Company Overview
10.3.2 Company Revenue
10.3.3 Products
10.3.4 Recent Developments
10.4. Medtronic
10.4.1 Company Overview
10.4.2 Company Revenue
10.4.3 Products
10.4.4 Recent Developments
10.5. Siemens Healthineers
10.5.1 Company Overview
10.5.2 Company Revenue
10.5.3 Products
10.5.4 Recent Developments
10.6. Analogic Corporation
10.6.1 Company Overview
10.6.2 Company Revenue
10.6.3 Products
10.6.4 Recent Developments
10.7. GE Healthcare
10.7.1 Company Overview
10.7.2 Company Revenue
10.7.3 Products
10.7.4 Recent Developments
10.8. Varian Medical Systems Inc.
10.8.1 Company Overview
10.8.2 Company Revenue
10.8.3 Products
10.8.4 Recent Developments
10.9. Brainlab AG
10.9.1 Company Overview
10.9.2 Company Revenue
10.9.3 Products
10.9.4 Recent Developments
10.10. Olympus Corporation
10.10.1 Company Overview
10.10.2 Company Revenue
10.10.3 Products
10.10.4 Recent Developments
10.11. Stryker
10.11.1 Company Overview
10.11.2 Company Revenue
10.11.3 Products
10.11.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies